Smart Eye - Hitting Inflection Point – Confirming Belief in No More Capital Needed
Redeye thinks the Q2 was strong - both confirming the inflection point in Automotive and regarding cash flow. With a strong pipeline of OEMs already in production further ramping up, combined with new OEMs entering and scaling production, Redeye thinks the Q2 acceleration is just the beginning of a long and strong growth journey. Redeye reiterates its view about Smart Eye not needing more capital injections before reachning positive cash flow. Redeye makes small adjustments to its fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/